Brentuximab vedotin for hematologic diseases

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 12 May 2011: Trial registered, NCT01352520

The trials

NCT01352520: SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP)

State
Under way
Phase
Phase 2
People
79 taking part
Started
Jun 2011
Primary completion
31 Jan 2028
Arms
SGN-35
Results
None posted
  1. 12 May 2011: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Also known as Adcetris.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.